Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -1259.87% is 85% above its 5-year average of -8249.06%, near the high end of its 5-year range (-57557.43%–-22.28%).
66.38% above its 12-month average of -3746.88%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -622.81%.
NET PROFIT MARGIN
-1259.87%
NET PROFIT MARGIN AVG TTM
-3746.88%
NET PROFIT MARGIN AVG 3Y
-11501.97%
NET PROFIT MARGIN AVG 5Y
-8249.06%
NET PROFIT MARGIN AVG 10Y
-1715.23%
NET PROFIT MARGIN AVG 15Y
-600.65%
NET PROFIT MARGIN AVG 20Y
-684.17%
CURRENT VS TTM AVG
+66.38%
CURRENT VS 3Y AVG
+89.05%
CURRENT VS 5Y AVG
+84.73%
CURRENT VS 10Y AVG
+26.55%
CURRENT VS 15Y AVG
-109.75%
CURRENT VS 20Y AVG
-84.14%
SECTOR MEDIAN · HEALTHCARE
-0.06%
median of 809 covered companies
CURRENT VS SECTOR MEDIAN
-2099683.33%
vs the sector median at left
Cytokinetics, Incorporated
Market Cap
$7.58B
Net Profit Margin
-1259.87%
TTM Avg
-3746.88%
3Y Avg
-11501.97%
5Y Avg
-8249.06%
Market Cap
$7.61B
Net Profit Margin
15.15%
TTM Avg
-46.46%
3Y Avg
-43.29%
5Y Avg
-43.29%
Market Cap
$7.61B
Net Profit Margin
17.36%
TTM Avg
12.22%
3Y Avg
6.75%
5Y Avg
3.72%
Market Cap
$7.63B
Net Profit Margin
0.00%
TTM Avg
-1068.74%
3Y Avg
-1793.84%
5Y Avg
-1195.89%
Market Cap
$7.29B
Net Profit Margin
-64.64%
TTM Avg
-52.37%
3Y Avg
-49.29%
5Y Avg
-43.60%
Market Cap
$7.92B
Net Profit Margin
55.22%
TTM Avg
39.84%
3Y Avg
-1987.81%
5Y Avg
-32826.44%
Market Cap
$8.01B
Net Profit Margin
10.62%
TTM Avg
-67.31%
3Y Avg
-92.57%
5Y Avg
-72.17%
Market Cap
$8.40B
Net Profit Margin
3.60%
TTM Avg
-1.75%
3Y Avg
-5.71%
5Y Avg
-20.27%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cytokinetics, Incorporated (CYTK) | $7.58B | -1259.87% | -3746.88% | -11501.97% | -8249.06% |
| Hinge Health, Inc. (HNGE)vs › | $7.61B | 15.15% | -46.46% | -43.29% | -43.29% |
| HealthEquity, Inc. (HQY)vs › | $7.61B | 17.36% | 12.22% | 6.75% | 3.72% |
| Praxis Precision Medicines, Inc. (PRAX)vs › | $7.63B | 0.00% | -1068.74% | -1793.84% | -1195.89% |
| Ionis Pharmaceuticals, Inc. (IONS)vs › | $7.29B | -64.64% | -52.37% | -49.29% | -43.60% |
| TG Therapeutics, Inc. (TGTX)vs › | $7.92B | 55.22% | 39.84% | -1987.81% | -32826.44% |
| Caris Life Sciences, Inc. (CAI)vs › | $8.01B | 10.62% | -67.31% | -92.57% | -72.17% |
| Alkermes plc (ALKS)vs › | $6.95B | 3.97% | 19.97% | 11.77% | 5.39% |
| Oscar Health, Inc. (OSCR)vs › | $8.40B | 3.60% | -1.75% | -5.71% | -20.27% |
| Chemed Corporation (CHE)vs › | $6.65B | 10.60% | 11.45% | 11.66% | 12.42% |
Operating Margin
-695.4%
Net Profit Margin
-1259.9%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -622.81% |
| 2026-03-31 | -1064.48% |
| 2025-12-31 | -1030.87% |
| 2025-09-30 | -15814.98% |
| 2025-06-30 | -201.25% |
| 2025-03-31 | -10220.14% |
| 2024-12-31 | -886.28% |
| 2024-09-30 | -34674.95% |
| 2024-06-30 | -57557.43% |
| 2024-03-31 | -16244.67% |
| 2023-12-31 | -8187.56% |
| 2023-09-30 | -34238.62% |
| 2023-06-30 | -14837.02% |
| 2023-03-31 | -2846.07% |
| 2022-12-31 | -7019.93% |
| 2022-09-30 | -5658.45% |
| 2022-06-30 | -22.28% |
| 2022-03-31 | -7791.38% |
| 2021-12-31 | -54.98% |
| 2021-09-30 | -1399.41% |
| 2021-06-30 | -2165.11% |
| 2021-03-31 | -719.36% |
| 2020-12-31 | -653.53% |
| 2020-09-30 | -7.62% |
| 2020-06-30 | -1134.98% |
| 2020-03-31 | -1030.20% |
| 2019-12-31 | -587.87% |
| 2019-09-30 | -488.41% |
| 2019-06-30 | -449.95% |
| 2019-03-31 | -346.95% |
| 2018-12-31 | -282.27% |
| 2018-09-30 | -206.91% |
| 2018-06-30 | -442.85% |
| 2018-03-31 | -574.81% |
| 2017-12-31 | 224916.67% |
| 2017-09-30 | -523.58% |
| 2017-06-30 | -952.54% |
| 2017-03-31 | -622.85% |
| 2016-12-31 | 21.60% |
| 2016-09-30 | 56.50% |
| 2016-06-30 | -200.12% |
| 2016-03-31 | -147.90% |
| 2015-12-31 | -94.59% |
| 2015-09-30 | -111.38% |
| 2015-06-30 | -161.28% |
| 2015-03-31 | -201.00% |
| 2014-12-31 | 38.80% |
| 2014-09-30 | -63.42% |
| 2014-06-30 | -107.52% |
| 2014-03-31 | -109.59% |
| 2013-12-31 | 26.82% |
| 2013-09-30 | -281.67% |
| 2013-06-30 | -1490.68% |
| 2013-03-31 | -1537.03% |
| 2012-12-31 | -524.54% |
| 2012-09-30 | -586.00% |
| 2012-06-30 | -485.77% |
| 2012-03-31 | -545.49% |
| 2011-12-31 | -1569.09% |
| 2011-09-30 | -745.55% |
| 2011-06-30 | -1294.59% |
| 2011-03-31 | -1534.99% |
| 2010-12-31 | -1056.69% |
| 2010-09-30 | -3132.23% |
| 2010-06-30 | -2845.02% |
| 2010-03-31 | -1962.80% |
| 2009-12-31 | -1224.73% |
| 2009-09-30 | -148.96% |
| 2009-06-30 | 77.80% |
| 2009-03-31 | -347.14% |
| 2008-12-31 | -344.42% |
| 2008-09-30 | -520.29% |
| 2008-06-30 | -499.80% |
| 2008-03-31 | -452.75% |
| 2007-12-31 | -426.11% |
| 2007-09-30 | -274.12% |
| 2007-06-30 | -397.48% |
| 2007-03-31 | -364.80% |
| 2006-12-31 | -10287.74% |
| 2006-09-30 | -14075.47% |
| 2006-06-30 | -953.39% |
| 2006-03-31 | -877.75% |
| 2005-12-31 | -516.84% |
| 2005-09-30 | -544.53% |
| 2005-06-30 | -450.23% |
| 2005-03-31 | -409.41% |
| 2004-12-31 | -531.00% |
| 2004-09-30 | -417.15% |
| 2004-06-30 | -318.31% |
| 2004-03-31 | -101.11% |
| 2003-12-31 | -309.04% |
| 2003-09-30 | -309.04% |
| 2003-06-30 | -302.86% |
| 2003-03-31 | -259.37% |
